Skip to main content
A-LevelBiologyImmunity9700/23 · May/June 2025 · Q611 Marks

Monoclonal antibodies can be used in the treatment of disease.

  1. (a)Describe how monoclonal antibodies are produced using the hybridoma method.[5]
  2. (b)Abciximab is a drug developed from a monoclonal antibody. Abciximab is used to prevent blood clotting in the coronary arteries in people with coronary heart disease. Abciximab prevents blood clotting by stopping structures called platelets from binding together. Fig. 6.1 shows platelets and abciximab in a coronary artery. [Figure 6.1] State the letter in Fig. 6.1 that represents: • the target antigen for abciximab • the constant region of abciximab • one of the antigen binding sites of abciximab ..[3]
  3. (c)Coronary arteries supply oxygenated blood to the cells of the heart. The passage outlines the cardiac cycle of the heart and the structures in the heart that control the cycle. Complete the passage by using the most appropriate scientific terms. The sinoatrial node is located in the wall of the .................................................................................... one of four chambers of the mammalian heart. Electrical impulses from the sinoatrial node reach the atrioventricular node, which transmits impulses towards the apex of the heart along a series of specialised muscle fibres called .................................................................... Pressure increases in the ventricles when they contract in the stage of the cardiac cycle known as ....................................................................[3]

This question uses a diagram from the original paper, which isn't shown here. Open the full paper from the past papers archive to see it.

Mark scheme

Marking points from the official mark scheme (May/June 2025). The mark or mark type is shown in brackets.

  1. [5] any five from:
  2. [5] 1 inject (non-self / foreign / specific) antigen into small mammal ; A named e.g. mouse
  3. [5] 2 ref. to leave time for immune response to occur (over several weeks) ; A immune response described
  4. [5] 3 remove splenocytes from the spleen (of mice) ; A plasma cells / B-lymphocytes / B-cells, for splenocytes
  5. [5] 4 fuse, splenocytes / AW, and, myeloma / tumour / cancer, cells;
  6. [5] 5 screen and select hybridoma cells ;
  7. [5] 6 clone selected hybridoma cells ;
  8. [5] 7 AVP; e.g. use of fusogen / polyethylene glycol ; separate hybridoma cells into separate wells ; ref. to HAT medium ; ref. to humanising monoclonal antibody
  9. [3] T / S ;
  10. [3] Q ;
  11. [3] R ;
  12. [3] right atrium;
  13. [3] Purkyne, tissue / fibres ; A Purkinje, tissue / fibres ; A Bundle of His
  14. [3] ventricular systole ;

Write your answer and get it marked

On Oracle Prep you can write or photograph your own answer and have it marked by AI against this mark scheme, with feedback on what you missed.

Sign up free →

About this question

Topic
Immunity, A-Level Biology (syllabus 9700). Structured question, 11 marks.
Source
A-Level Biology, May/June 2025 Paper 2 Variant 3, question 6.

Questions and mark schemes are from past examination papers and remain the copyright of the exam board. How Oracle Prep builds its content

Related Biology questions

© 2026 Oracle Prep